Amgen Operating Income vs Total Assets Analysis

AMGN Stock  USD 284.32  1.98  0.69%   
Amgen financial indicator trend analysis is way more than just evaluating Amgen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amgen Inc is a good investment. Please check the relationship between Amgen Operating Income and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Operating Income vs Total Assets

Operating Income vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amgen Inc Operating Income account and Total Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Amgen's Operating Income and Total Assets is 0.58. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Total Assets in the same time period over historical financial statements of Amgen Inc, assuming nothing else is changed. The correlation between historical values of Amgen's Operating Income and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Amgen Inc are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Operating Income i.e., Amgen's Operating Income and Total Assets go up and down completely randomly.

Correlation Coefficient

0.58
Relationship DirectionPositive 
Relationship StrengthWeak

Operating Income

Operating Income is the amount of profit realized from Amgen Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Amgen Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Total Assets

Total assets refers to the total amount of Amgen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amgen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Amgen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amgen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
At this time, Amgen's Selling General Administrative is very stable compared to the past year. As of the 29th of March 2024, Tax Provision is likely to grow to about 1.4 B, while Enterprise Value Multiple is likely to drop 9.83.
 2021 2022 2023 2024 (projected)
Interest Expense1.2B1.4B2.9B3.0B
Depreciation And Amortization3.4B3.4B4.1B4.3B

Amgen fundamental ratios Correlations

0.930.740.810.330.650.94-0.40.670.860.630.350.78-0.490.92-0.190.470.910.630.520.260.760.810.790.370.77
0.930.890.91-0.010.470.99-0.610.830.950.840.020.94-0.550.99-0.250.720.990.810.210.120.950.820.640.080.6
0.740.890.95-0.370.390.85-0.880.930.920.95-0.30.99-0.730.92-0.210.840.940.9-0.07-0.060.930.880.58-0.290.54
0.810.910.95-0.230.470.88-0.810.870.90.83-0.120.94-0.760.92-0.290.730.950.820.10.250.880.890.67-0.120.63
0.33-0.01-0.37-0.230.390.070.66-0.35-0.12-0.440.88-0.290.37-0.050.17-0.51-0.09-0.360.790.36-0.27-0.110.310.880.36
0.650.470.390.470.390.46-0.320.420.470.210.40.4-0.530.480.220.10.490.350.630.280.30.590.960.270.95
0.940.990.850.880.070.46-0.530.760.930.790.090.89-0.510.98-0.320.680.970.760.270.170.920.80.630.160.59
-0.4-0.61-0.88-0.810.66-0.32-0.53-0.85-0.71-0.810.56-0.820.79-0.660.13-0.74-0.7-0.790.330.11-0.72-0.76-0.460.62-0.43
0.670.830.930.87-0.350.420.76-0.850.850.88-0.310.94-0.580.850.080.790.870.87-0.1-0.10.890.770.56-0.320.51
0.860.950.920.9-0.120.470.93-0.710.850.88-0.180.95-0.650.96-0.260.740.960.830.040.010.940.850.65-0.140.61
0.630.840.950.83-0.440.210.79-0.810.880.88-0.440.95-0.610.86-0.220.90.860.91-0.24-0.280.930.740.39-0.390.34
0.350.02-0.3-0.120.880.40.090.56-0.31-0.18-0.44-0.260.210.00.09-0.48-0.03-0.340.940.49-0.28-0.010.350.970.39
0.780.940.990.94-0.290.40.89-0.820.940.950.95-0.26-0.650.95-0.170.840.960.91-0.04-0.040.970.840.58-0.230.53
-0.49-0.55-0.73-0.760.37-0.53-0.510.79-0.58-0.65-0.610.21-0.65-0.610.39-0.5-0.65-0.6-0.07-0.14-0.51-0.81-0.680.31-0.65
0.920.990.920.92-0.050.480.98-0.660.850.960.860.00.95-0.61-0.260.721.00.810.20.070.930.880.670.040.62
-0.19-0.25-0.21-0.290.170.22-0.320.130.08-0.26-0.220.09-0.170.39-0.26-0.2-0.27-0.130.06-0.26-0.2-0.280.03-0.010.05
0.470.720.840.73-0.510.10.68-0.740.790.740.9-0.480.84-0.50.72-0.20.730.96-0.31-0.250.840.590.24-0.420.18
0.910.990.940.95-0.090.490.97-0.70.870.960.86-0.030.96-0.651.0-0.270.730.830.180.110.930.890.680.010.63
0.630.810.90.82-0.360.350.76-0.790.870.830.91-0.340.91-0.60.81-0.130.960.83-0.13-0.160.870.730.47-0.320.43
0.520.21-0.070.10.790.630.270.33-0.10.04-0.240.94-0.04-0.070.20.06-0.310.18-0.130.5-0.090.220.60.890.61
0.260.12-0.060.250.360.280.170.11-0.10.01-0.280.49-0.04-0.140.07-0.26-0.250.11-0.160.5-0.070.050.310.470.32
0.760.950.930.88-0.270.30.92-0.720.890.940.93-0.280.97-0.510.93-0.20.840.930.87-0.09-0.070.740.47-0.190.4
0.810.820.880.89-0.110.590.8-0.760.770.850.74-0.010.84-0.810.88-0.280.590.890.730.220.050.740.77-0.050.76
0.790.640.580.670.310.960.63-0.460.560.650.390.350.58-0.680.670.030.240.680.470.60.310.470.770.240.99
0.370.08-0.29-0.120.880.270.160.62-0.32-0.14-0.390.97-0.230.310.04-0.01-0.420.01-0.320.890.47-0.19-0.050.240.26
0.770.60.540.630.360.950.59-0.430.510.610.340.390.53-0.650.620.050.180.630.430.610.320.40.760.990.26
Click cells to compare fundamentals

Amgen Account Relationship Matchups

Amgen fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets59.7B62.9B61.2B65.1B97.2B102.0B
Short Long Term Debt Total29.9B33.0B33.3B38.9B64.6B67.8B
Other Current Liab8.5B10.1B10.7B12.5B15.4B16.1B
Total Current Liabilities12.8B11.7B12.2B15.7B18.4B19.3B
Total Stockholder Equity9.7B9.4B6.7B3.7B6.2B12.3B
Property Plant And Equipment Net4.9B4.9B5.2B5.4B5.9B3.6B
Net Debt23.9B26.7B25.3B31.3B53.7B56.4B
Retained Earnings(21.3B)(21.4B)(24.6B)(28.6B)(26.5B)(25.2B)
Cash6.0B6.3B8.0B7.6B10.9B11.5B
Non Current Assets Total41.3B41.8B41.8B42.9B66.8B70.2B
Non Currrent Assets Other2.2B5.6B6.5B5.9B9.6B10.1B
Cash And Short Term Investments8.9B10.6B8.0B9.3B10.9B10.5B
Net Receivables4.1B4.5B4.9B5.6B7.9B8.3B
Common Stock Shares Outstanding609M590M573M541M538M759.2M
Liabilities And Stockholders Equity59.7B62.9B61.2B65.1B97.2B102.0B
Non Current Liabilities Total37.2B41.9B42.3B45.8B72.5B76.2B
Other Current Assets1.9B2.1B2.4B2.4B281M267.0M
Other Stockholder Equity(528M)(985M)18.2B21.7B25.0B26.2B
Total Liab50.0B53.5B54.5B61.5B90.9B95.5B
Property Plant And Equipment Gross4.9B4.9B14.0B14.7B15.7B16.5B
Total Current Assets18.4B21.1B19.4B22.2B30.3B15.2B
Accumulated Other Comprehensive Income(528M)(985M)(796M)(231M)(289M)(274.6M)
Short Term Debt3.0B91M87M1.6B1.4B1.0B
Inventory3.6B3.9B4.1B4.9B9.5B10.0B
Accounts Payable1.4B1.4B1.4B1.6B1.6B1.7B
Common Stock Total Equity31.5B31.8B32.1B32.5B37.4B27.1B
Short Term Investments2.9B4.4B48M1.7B10.9B12.2B
Common Stock31.5B31.8B32.1B32.5B33.1B27.5B
Other Assets955M1.3B6.5B2.2B2.5B1.4B
Long Term Debt27.0B32.9B33.2B37.4B63.2B66.3B
Property Plant Equipment4.9B4.9B5.2B5.4B6.2B5.3B
Good Will14.7B14.7B14.9B15.5B18.6B14.4B
Intangible Assets19.4B16.6B15.2B16.1B32.6B34.3B
Other Liab9.9B9.0B9.1B7.9B9.1B5.1B
Net Tangible Assets(24.4B)(21.9B)(23.4B)(27.9B)(25.2B)(23.9B)
Retained Earnings Total Equity(21.3B)(21.4B)(24.6B)(28.6B)(25.8B)(24.5B)
Long Term Debt Total27.0B32.9B33.2B37.4B43.0B29.9B
Non Current Liabilities Other9.6B9.0B2.5B2.7B2.3B2.2B

Amgen Investors Sentiment

The influence of Amgen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amgen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Amgen's public news can be used to forecast risks associated with an investment in Amgen. The trend in average sentiment can be used to explain how an investor holding Amgen can time the market purely based on public headlines and social activities around Amgen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amgen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amgen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amgen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Amgen.

Amgen Implied Volatility

    
  20.28  
Amgen's implied volatility exposes the market's sentiment of Amgen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amgen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amgen stock will not fluctuate a lot when Amgen's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amgen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amgen's short interest history, or implied volatility extrapolated from Amgen options trading.

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amgen Stock

  0.62MBIO Mustang Bio Report 3rd of April 2024 PairCorr

Moving against Amgen Stock

  0.79EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.65DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.6MDWD Mediwound Downward RallyPairCorr
  0.58MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.51YS YS Biopharma Report 22nd of April 2024 PairCorr
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.52
Earnings Share
12.48
Revenue Per Share
52.692
Quarterly Revenue Growth
0.198
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.